Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 826751, 7 pages
http://dx.doi.org/10.1093/ecam/nep219
Original Article

Observed Changes in Risk during Naturopathic Treatment of Hypertension

1Bastyr University, Kenmore, WA 98028, USA
2University of Washington, Institute for Translation Health Sciences, Seattle, USA
3University of Washington, Department of Epidemiology, Seattle, WA 98195, USA
4University of Washington, Department of Cardiology, Seattle, WA 98195, USA

Received 23 July 2009; Accepted 25 November 2009

Copyright © 2011 Ryan Bradley et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. S. Vokonas, W. B. Kannel, and L. A. Cupples, “Epidemiology and risk of hypertension in the elderly: the Framingham study,” Journal of Hypertension, vol. 6, no. 1, pp. S3–S9, 1988. View at Google Scholar · View at Scopus
  2. Q. Gu, V. L. Burt, R. Paulose-Ram, S. Yoon, and R. F. Gillum, “High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study,” Annals of Epidemiology, vol. 18, no. 4, pp. 302–309, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report,” Journal of the American Medical Association, vol. 289, no. 19, pp. 2560–2572, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. B. A. Steinberg, D. L. Bhatt, S. Mehta et al., “Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease,” American Heart Journal, vol. 156, no. 4, pp. 719–727, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. L. J. Appel, M. W. Brands, S. R. Daniels, N. Karanja, P. J. Elmer, and F. M. Sacks, “Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association,” Hypertension, vol. 47, no. 2, pp. 296–308, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. P. C. Heaton and S. M. Frede, “Patients' need for more counseling on diet, exercise, and smoking cessation: results from the National Ambulatory Medical Care Survey,” Journal of the American Pharmacists Association, vol. 46, no. 3, pp. 364–369, 2006. View at Google Scholar · View at Scopus
  7. R. Bradley and E. B. Oberg, “Naturopathic medicine and type 2 diabetes: a retrospective analysis from an academic clinic,” Alternative Medicine Review, vol. 11, no. 1, pp. 30–39, 2006. View at Google Scholar · View at Scopus
  8. R. Bradley, E. Kozura, H. Buckle, J. Kaltunas, S. Tais, and L. J. Standish, “Description of clinical risk factor changes during naturopathic care for type 2 diabetes,” Journal of Alternative and Complementary Medicine, vol. 15, no. 6, pp. 633–638, 2009. View at Google Scholar · View at Scopus
  9. J. C. E. Chinnock, K. Tippens, and C‘. Calabrese, “Survey of naturopathic treatment of diabetes,” Poster Presentation at the American Association of Naturopathic Physicians Annual Convention, Palm Springs, Calif, USA, August 2007. View at Google Scholar
  10. C. Buettner, R. S. Phillips, R. B. Davis, P. Gardiner, and M. A. Mittleman, “Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks,” American Journal of Cardiology, vol. 99, no. 5, pp. 661–666, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. M. J. Wood, R. L. Stewart, H. Merry, D. E. Johnstone, and J. L. Cox, “Use of complementary and alternative medical therapies in patients with cardiovascular disease,” American Heart Journal, vol. 145, no. 5, pp. 806–812, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. L. Chagan, A. Ioselovich, L. Asherova, and J. W. M. Cheng, “Use of alternative pharmacotherapy in management of cardiovascular diseases,” American Journal of Managed Care, vol. 8, no. 3, pp. 270–285, 2002. View at Google Scholar · View at Scopus
  13. M. Rakobowchuk, S. Tanguay, K. A. Burgomaster, K. R. Howarth, M. J. Gibala, and M. J. MacDonald, “Sprint interval and traditional endurance training induce similar improvements in peripheral arterial stiffness and flow-mediated dilation in healthy humans,” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, vol. 295, pp. R236–R242, 2008. View at Google Scholar
  14. J. H. O'Keefe, N. M. Gheewala, and J. O. O'Keefe, “Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health,” Journal of the American College of Cardiology, vol. 51, no. 3, pp. 249–255, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. Bo and E. Pisu, “Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes,” Current Opinion in Lipidology, vol. 19, no. 1, pp. 50–56, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. E. Fosslien, “Review: mitochondrial medicine—molecular pathology of defective oxidative phosphorylation,” Annals of Clinical and Laboratory Science, vol. 33, pp. 371–395, 2003. View at Google Scholar · View at Scopus
  17. J. M. Rigelsky and B. V. Sweet, “Hawthorn: pharmacology and therapeutic uses,” American Journal of Health-System Pharmacy, vol. 59, no. 5, pp. 417–422, 2002. View at Google Scholar · View at Scopus
  18. T. A. Mori and L. J. Beilin, “Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction,” Current Opinion in Lipidology, vol. 12, no. 1, pp. 11–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Shibuya and K. Sato, “Fluorescence histochemical studies of the effects of rauwolfia alkaloid derivatives on adrenergic vasomotor nerves,” International Journal of Clinical Pharmacology Therapy and Toxicology, vol. 23, no. 1, pp. 5–10, 1985. View at Google Scholar · View at Scopus
  20. J. Wu, A. T. Kraja, A. Oberman et al., “A summary of the effects of antihypertensive medications on measured blood pressure,” American Journal of Hypertension, vol. 18, no. 7, pp. 935–942, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. J. M. E. Walsh, K. M. McDonald, K. G. Shojania et al., “Quality improvement strategies for hypertension management: a systematic review,” Medical Care, vol. 44, no. 7, pp. 646–657, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. R. C. Oh, S. A. Beresford, and W. E. Lafferty, “The fish in secondary prevention of heart disease (FISH) survey—primary care physicians and omega3 fatty acid prescribing behaviors,” The Journal of the American Board of Family Medicine, vol. 19, pp. 459–467, 2006. View at Google Scholar
  23. P. M. Kris-Etherton, W. S. Harris, and L. J. Appel, “Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease,” Circulation, vol. 106, no. 21, pp. 2747–2757, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Eyre, R. Kahn, R. M. Robertson, N. G. Clark, C. Doyle, and Y. Hong, “Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association,” Stroke, vol. 35, pp. 1999–2010, 2004. View at Google Scholar
  25. Agency for Healthcare Research and Quality (AHRQ), The Guide to Clinical Preventive Services: Recommendations of the U.S. Preventive Services Task Force, AHRQ Press, Rockville, Md, USA, 2006.
  26. D. M. Lloyd-Jones, J. C. Evans, and D. Levy, “Hypertension in adults across the age spectrum: current outcomes and control in the community,” Journal of the American Medical Association, vol. 294, no. 4, pp. 466–472, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins, “Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies,” Lancet, vol. 360, pp. 1903–1913, 2002. View at Google Scholar
  28. F. Gohar, S. M. Greenfield, D. Gareth Beevers, G. Y. H. Lip, and K. Jolly, “Self-care and adherence to medication: a survey in the hypertension outpatient clinic,” BMC Complementary and Alternative Medicine, vol. 8, no. 1, article no. 4, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. M. C. Morris, F. Sacks, and B. Rosner, “Does fish oil lower blood pressure? A meta-analysis of controlled trials,” Circulation, vol. 88, no. 2, pp. 523–533, 1993. View at Google Scholar · View at Scopus
  30. L. J. Appel, E. R. Miller III, A. J. Seidler, and P. K. Whelton, “Does supplementation of diet with ‘fish oil’ reduce blood pressure? A meta-analysis of controlled clinical trials,” Archives of Internal Medicine, vol. 153, no. 12, pp. 1429–1438, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. B. E. Burke, R. Neuenschwander, and R. D. Olson, “Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension,” Southern Medical Journal, vol. 94, no. 11, pp. 1112–1117, 2001. View at Google Scholar · View at Scopus
  32. P. Langsjoen, P. Langsjoen, R. Willis, and K. Folkers, “Treatment of essential hypertension with Coenzyme Q10,” Molecular Aspects of Medicine, vol. 15, supplement, pp. S265–S272, 1994. View at Google Scholar · View at Scopus
  33. R. B. Singh, M. A. Niaz, S. S. Rastogi, P. K. Shukla, and A. S. Thakur, “Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease,” Journal of Human Hypertension, vol. 13, pp. 203–208, 1999. View at Google Scholar
  34. E. Ernst, “How much of CAM is based on research evidence?” Evidence-Based Complementary and Alternative Medicine, 2009. View at Publisher · View at Google Scholar · View at PubMed